| Title : A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy - Ji_2023_Diabetes.Obes.Metab_25_3788 |
| Author(s) : Ji L , Lu J , Gao L , Yan X , Li J , Cheng Z , Zhang L , Tian J , Li P , Bai J , Xie D , Zhao J , Ding J , Yu Q , Wang T |
| Ref : Diabetes Obes Metab , 25 :3788 , 2023 |
| Abstract : Ji_2023_Diabetes.Obes.Metab_25_3788 |
| ESTHER : Ji_2023_Diabetes.Obes.Metab_25_3788 |
| PubMedSearch : Ji_2023_Diabetes.Obes.Metab_25_3788 |
| PubMedID: 37724698 |
Ji L, Lu J, Gao L, Yan X, Li J, Cheng Z, Zhang L, Tian J, Li P, Bai J, Xie D, Zhao J, Ding J, Yu Q, Wang T (2023)
A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy
Diabetes Obes Metab
25 :3788
Ji L, Lu J, Gao L, Yan X, Li J, Cheng Z, Zhang L, Tian J, Li P, Bai J, Xie D, Zhao J, Ding J, Yu Q, Wang T (2023)
Diabetes Obes Metab
25 :3788